What does the evidence say about Bergamot Lipid Profile Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Bergamot Lipid Profile Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Bergamot ( Citrus bergamia ), a flavonoid-rich nutraceutical, has shown potential cardiometabolic benefits, yet evidence from human trials remains inconsistent. [Chambari M (2026); evidence level 1] - This systematic review and dose-response meta-analysis evaluated the effects of bergamot ( Citrus bergamia ) on cardiovascular disease risk factors in adults. [Chambari M (2026); evidence level 1] - The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. [Chambari M (2026); evidence level 1] - Introduction According to the common definition, nutraceuticals are components found in food that can act as therapeutic substances. [Morze J (2020); evidence level 1] - Each stage of the review, including the study section, data extraction, and risk of bias and quality of evidence assessments, will be performed in duplicate. [Morze J (2020); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.